HIV Infection Clinical Trials

166 recruitingLast updated: June 17, 2026

There are 166 actively recruiting hiv infection clinical trials across 49 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 4, Phase 3. Top locations include New York, New York, United States, San Francisco, California, United States, Houston, Texas, United States. Updated daily from ClinicalTrials.gov.


HIV Infection Trials at a Glance

166 actively recruiting trials for hiv infection are listed on ClinicalTrialsFinder across 6 cities in 49 countries. The largest study group is Not Applicable with 76 trials, with the heaviest enrollment activity in New York, San Francisco, and Houston. Lead sponsors running hiv infection studies include ViiV Healthcare, University of California, San Francisco, and Columbia University.

Browse hiv infection trials by phase

Treatments under study

About HIV Infection Clinical Trials

Looking for clinical trials for HIV Infection? There are currently 24 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new HIV Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about HIV Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 166 trials

Recruiting
Not Applicable

Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People

HIV InfectionsSubstance Use Disorders
Medical University of South Carolina50 enrolled1 locationNCT05816083
Recruiting
Not Applicable

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study

HIV InfectionTobacco-Related Carcinoma
AIDS Malignancy Consortium100 enrolled11 locationsNCT04949464
Recruiting
Phase 1

Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)40 enrolled9 locationsNCT06665646
Recruiting

Skeletal Muscle Energetics and Fatiguability in Older Individuals

HIV InfectionsHIV
Johns Hopkins University200 enrolled1 locationNCT04142047
Recruiting
Not Applicable

An Effectiveness Trial of the PrEP for WINGS Study

HIV InfectionsAlcohol Use DisorderViolence, Gender-Based
Columbia University307 enrolled1 locationNCT06853314
Recruiting
Phase 1

Dasatinib for HIV-1 Reservoir Reduction

HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)14 enrolled3 locationsNCT07342491
Recruiting

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Anal CarcinomaMalignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+9 more
AIDS Malignancy Consortium200 enrolled8 locationsNCT05663502
Recruiting
Not Applicable

Testing the WeCare Intervention to Address Mental Health and Medication Adherence Challenges Among MSM in South Africa

HIV InfectionsMental Health
Emory University60 enrolled1 locationNCT07226323
Recruiting

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

HIV Infections
Gilead Sciences3,000 enrolled17 locationsNCT07473778
Recruiting
Phase 1Phase 2

The Tatelo Plus Study

HIV InfectionsHIV
National Institute of Allergy and Infectious Diseases (NIAID)41 enrolled2 locationsNCT06508749
Recruiting

Protocol RV 583 Multinational Observational Cohort of HIV and Other Infections

HIV Infections
Henry M. Jackson Foundation for the Advancement of Military Medicine2,500 enrolled4 locationsNCT05147519
Recruiting
Not Applicable

An Adaptive Randomized Controlled Trial

HIV InfectionsMulti Drug Resistant Tuberculosis
Columbia University360 enrolled1 locationNCT05633056
Recruiting
Not Applicable

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

HIV InfectionsCervix CancerHPV Infection
UNC Lineberger Comprehensive Cancer Center7,597 enrolled1 locationNCT07428330
Recruiting
Not Applicable

The TAIL-PrEP Study

HIV Infections
Columbia University30 enrolled1 locationNCT06868641
Recruiting
Phase 3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

HIV Infections
ViiV Healthcare332 enrolled89 locationsNCT06694805
Recruiting
Phase 1

MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)

HIV Infection
Merck Sharp & Dohme LLC28 enrolled2 locationsNCT07042945
Recruiting
Phase 1Phase 2

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)1,120 enrolled46 locationsNCT02140255
Recruiting
Phase 4

Menopausal HT for Women Living With HIV (HoT)

MenopauseHIV Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections105 enrolled23 locationsNCT06856174
Recruiting
Not Applicable

A Setting Focus Overdose Prevention Intervention

HIV InfectionsHCVDrug Overdose
Johns Hopkins Bloomberg School of Public Health285 enrolled1 locationNCT05320835
Recruiting
Phase 1Phase 2

A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1

HIV Infections
ViiV Healthcare44 enrolled1 locationNCT07275606